BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29986708)

  • 1. A role for telomere length and chromosomal damage in idiopathic pulmonary fibrosis.
    McDonough JE; Martens DS; Tanabe N; Ahangari F; Verleden SE; Maes K; Verleden GM; Kaminski N; Hogg JC; Nawrot TS; Wuyts WA; Vanaudenaerde BM
    Respir Res; 2018 Jul; 19(1):132. PubMed ID: 29986708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
    van Batenburg AA; Kazemier KM; van Oosterhout MFM; van der Vis JJ; van Es HW; Grutters JC; Goldschmeding R; van Moorsel CHM
    PLoS One; 2020; 15(1):e0226785. PubMed ID: 31910222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study.
    Duckworth A; Gibbons MA; Allen RJ; Almond H; Beaumont RN; Wood AR; Lunnon K; Lindsay MA; Wain LV; Tyrrell J; Scotton CJ
    Lancet Respir Med; 2021 Mar; 9(3):285-294. PubMed ID: 33197388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers of telomere dysfunction and senescence are common findings in the usual interstitial pneumonia pattern of lung fibrosis.
    Lee JS; La J; Aziz S; Dobrinskikh E; Brownell R; Jones KD; Achtar-Zadeh N; Green G; Elicker BM; Golden JA; Matthay MA; Kukreja J; Schwartz DA; Wolters PJ
    Histopathology; 2021 Jul; 79(1):67-76. PubMed ID: 33432658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.
    Verleden SE; Tanabe N; McDonough JE; Vasilescu DM; Xu F; Wuyts WA; Piloni D; De Sadeleer L; Willems S; Mai C; Hostens J; Cooper JD; Verbeken EK; Verschakelen J; Galban CJ; Van Raemdonck DE; Colby TV; Decramer M; Verleden GM; Kaminski N; Hackett TL; Vanaudenaerde BM; Hogg JC
    Lancet Respir Med; 2020 Jun; 8(6):573-584. PubMed ID: 32061334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of Idiopathic Pulmonary Fibrosis Assessed by a Combination of Microcomputed Tomography, Histology, and Immunohistochemistry.
    Tanabe N; McDonough JE; Vasilescu DM; Ikezoe K; Verleden SE; Xu F; Wuyts WA; Vanaudenaerde BM; Colby TV; Hogg JC
    Am J Pathol; 2020 Dec; 190(12):2427-2435. PubMed ID: 32919981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A concise review of telomere and telomerase-related genetic markers in fibrotic lung diseases].
    Fan YL; Ye Q
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2020 Dec; 38(12):952-956. PubMed ID: 33406566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis.
    Planas-Cerezales L; Arias-Salgado EG; Buendia-Roldán I; Montes-Worboys A; López CE; Vicens-Zygmunt V; Hernaiz PL; Sanuy RL; Leiro-Fernandez V; Vilarnau EB; Llinás ES; Sargatal JD; Abellón RP; Selman M; Molina-Molina M
    Respirology; 2019 Feb; 24(2):146-153. PubMed ID: 30320420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.
    Dai J; Cai H; Zhuang Y; Wu Y; Min H; Li J; Shi Y; Gao Q; Yi L
    Respirology; 2015 Jan; 20(1):122-8. PubMed ID: 25346280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aging lung: tissue telomere shortening in health and disease.
    Everaerts S; Lammertyn EJ; Martens DS; De Sadeleer LJ; Maes K; van Batenburg AA; Goldschmeding R; van Moorsel CHM; Dupont LJ; Wuyts WA; Vos R; Gayan-Ramirez G; Kaminski N; Hogg JC; Janssens W; Verleden GM; Nawrot TS; Verleden SE; McDonough JE; Vanaudenaerde BM
    Respir Res; 2018 May; 19(1):95. PubMed ID: 29751799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung transplantation for idiopathic pulmonary fibrosis enriches for individuals with telomere-mediated disease.
    Alder JK; Sutton RM; Iasella CJ; Nouraie M; Koshy R; Hannan SJ; Chan EG; Chen X; Zhang Y; Brown M; Popescu I; Veatch M; Saul M; Berndt A; Methé BA; Morris A; Pilewski JM; Sanchez PG; Morrell MR; Shapiro SD; Lindell KO; Gibson KF; Kass DJ; McDyer JF
    J Heart Lung Transplant; 2022 May; 41(5):654-663. PubMed ID: 34933798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis.
    Liu YY; Shi Y; Liu Y; Pan XH; Zhang KX
    Acta Pharmacol Sin; 2018 Nov; 39(11):1735-1745. PubMed ID: 29925920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.
    Stuart BD; Lee JS; Kozlitina J; Noth I; Devine MS; Glazer CS; Torres F; Kaza V; Girod CE; Jones KD; Elicker BM; Ma SF; Vij R; Collard HR; Wolters PJ; Garcia CK
    Lancet Respir Med; 2014 Jul; 2(7):557-65. PubMed ID: 24948432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of telomere dysfunction in lung fibrosis.
    Molina-Molina M; Borie R
    Curr Opin Pulm Med; 2018 Sep; 24(5):440-444. PubMed ID: 30067250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomeres in Interstitial Lung Disease: The Short and the Long of It.
    Courtwright AM; El-Chemaly S
    Ann Am Thorac Soc; 2019 Feb; 16(2):175-181. PubMed ID: 30540921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapulmonary manifestations of a telomere syndrome in patients with idiopathic pulmonary fibrosis are associated with decreased survival.
    Hoffman TW; van der Vis JJ; Biesma DH; Grutters JC; van Moorsel CHM
    Respirology; 2022 Nov; 27(11):959-965. PubMed ID: 35419815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomerase and telomere length in pulmonary fibrosis.
    Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis.
    Ikezoe K; Hackett TL; Peterson S; Prins D; Hague CJ; Murphy D; LeDoux S; Chu F; Xu F; Cooper JD; Tanabe N; Ryerson CJ; Paré PD; Coxson HO; Colby TV; Hogg JC; Vasilescu DM
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1048-1059. PubMed ID: 34343057
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigation of telomere related gene mutations in idiopathic pulmonary fibrosis.
    Yildirim H; Yildiz P; Coskunpinar E
    Mol Biol Rep; 2020 Oct; 47(10):7851-7860. PubMed ID: 33006015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.